Nurix Therapeutics Announces Proposed Public Offering

SAN FRANCISCO, April 11, 2024 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company developing...

Related Keywords

California ,United States ,San Francisco ,Edgewood ,Jason Kantor ,Aljanae Reynolds ,Elizabeth Wolffe ,Nasdaq ,Nicolaus Company Incorporated ,Broadridge Financial Solutions ,Jp Morgan Securities ,Prospectus Department ,Piper Sandler Co ,Capital Markets ,Nurix Therapeutics Inc ,Exchange Commission ,Needham Company ,Piper Sandler ,Post Effective Amendment ,Island Avenue ,One Montgomery Street ,Nurix Therapeutics ,Casitasb Lineage ,Securities Litigation Reform Act ,